These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23156085)

  • 21. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
    Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
    Zobnin IuV; Petrova AG; Provado IP; Afanas'ev VV
    Eksp Klin Farmakol; 2011; 74(10):39-42. PubMed ID: 22238986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions].
    Suslina ZA; Romantsov MG; Kovalenko AL; Klocheva EG; Rumintseva SA; Bagnenko SF; Piradov MA; Semke VIa; Sukhanov DS
    Klin Med (Mosk); 2010; 88(4):61-7. PubMed ID: 20919573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy].
    Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN
    Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoflavin in the treatment of patients with chronic abacterial prostatitis and erectile dysfunction].
    Churakov AA; Kolesnikov AI; Bliumberg BI; Popkov VM
    Urologiia; 2012; (5):64-6, 68. PubMed ID: 23342619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological correction of hypoxia in patients with severe carbon monoxide poisoning].
    Shilov VV; Andrianov AIu; Vasil'ev SA; Batotsyrenova KhV; Loladze AT
    Georgian Med News; 2012 Apr; (205):31-8. PubMed ID: 22665729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
    Tsygan IV
    Voen Med Zh; 2013 Nov; 334(11):30-5. PubMed ID: 24611306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correction of mnestico-intellectual disturbances in the somatogenic phase of acute poisoning with a mixture of psychotropic drugs].
    Shilov VV; Aleksandrov MV; Vasil'ev SA; Batotsyrenov BV; Kuznetsov OA
    Klin Med (Mosk); 2012; 90(3):63-5. PubMed ID: 22690570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
    Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
    Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
    Lavrik SIu; Domitrak SV; Shprakh VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):37-41. PubMed ID: 21512499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of metabolic drugs and psychotherapy in dental implantation in elderly patients].
    Parfenov SA; Volodina KI; Vorob'eva NV
    Stomatologiia (Mosk); 2013; 92(5):40-3. PubMed ID: 24300707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antioxidant therapy in discirculatory encephalopathy].
    Antipenko EA; Gustov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia].
    Zadnipryanyi IV; Tretyakova OS; Sataeva TP
    Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postoperative correction of the methabolism of the single lung after pulmonectomy].
    Iakovlev AIu; Gordeeva OS; Denisenko AN; Vorontsov AIu; Ulitin DN
    Khirurgiia (Mosk); 2011; (4):47-50. PubMed ID: 21728254
    [No Abstract]   [Full Text] [Related]  

  • 38. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
    Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
    Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correction of metabolic disturbances in cancer patients in the early postanesthesia period].
    Fatullaeva KF; Nurov AU; Saltanov AI
    Khirurgiia (Mosk); 2010; (4):54-7. PubMed ID: 20521428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.